LEVATED ICP has been recognized as one of the most important factors affecting morbidity and mortality rates in patients who have suffered TBI; 23, 24, 34 therefore, ICP monitoring has become routine in the management of severe head injuries in both adults and children. A variety of monitoring techniques and devices are available, each with advantages and disadvantages. An EVD is considered the gold standard for accurate ICP monitoring, and it allows for drainage of CSF, a potentially important means to lower elevated pressures.
Overall, insertion of an ICP monitor is thought to be a safe and effective adjunct in the management of raised ICP, producing a low incidence of hemorrhagic or infectious complications. 1, 2, 4, 5, 13, 16, 17, 20, 22, 26, [30] [31] [32] [33] [34] 39, 41 Authors of the majority of studies have focused on adult patients in whom ICP monitors have been placed for a variety of reasons, including head trauma, metabolic coma, hydrocephalus, and postoperative craniotomy. There are few studies in the literature in which these issues are addressed in the pediatric population. 5, 16, 33 Authors of a recently published report described the hemorrhagic complications of fiberoptic intraparenchymal monitors in children. 5 When monitoring ICP, however, many surgeons prefer to use EVDs alone or concomitant with fiberoptic devices when possible because of the added benefit of drainage of CSF to reduce elevated ICP. Although the complication rates associated with EVDs have been examined in detail in previous reports, children, it is certainly possible that both the hemorrhagic and infection complication rates in this group of patients may differ substantially from those reported previously. The purpose of this study was to examine a consecutive series of children with TBI in whom an ICP monitor had been placed and to compare the incidence of complications (hemorrhagic, infectious, and malpositioning) after insertion of an EVD, a fiberoptic intraparenchymal ICP monitor, or both.
Clinical Material and Methods

Patient Population
Between 1998 and 2003, a total of 80 children admitted to Primary Children's Medical Center after sustaining head trauma were evaluated and met criteria for insertion of an ICP monitoring device (EVD, intraparenchymal fiberoptic monitor, or both). The mean age of this group was 8.5 years (range 0.5-18 years). There were 51 boys (64%) and 29 girls (36%). Criteria for ICP monitoring were standardized and included children with an initial Glasgow Coma Scale score of less than 8, with evidence of intracranial injury or elevated ICP (such as, effacement of cisterns) on head CT scans. 15, 19 Prior to placement of either an EVD or fiberoptic ICP monitor, the results of normal coagulation studies and platelet levels were confirmed. Children who had undergone placement of an ICP monitoring device after elective intracranial procedures or for the treatment of hydrocephalus were excluded from this study.
Study Methodology
A retrospective review of patients' hospital charts, laboratory studies, and radiographic studies was conducted. Head CT scans obtained at admission and after placement of an ICP monitoring device were available in all patients included in the study. Unless unusual circumstances arose, postprocedure CT scans were obtained within 24 hours (maximum 5 days after insertion). All CT scans were reviewed and graded by the authors based on a previously published scale. 5 
ICP Monitoring Devices
Patients who underwent placement of a fiberoptic intraparenchymal monitor (Camino; Integra LifeSciences, Plainsboro, NJ), an EVD, or both were included in this study. Monitoring devices in all patients were placed at the bedside in the pediatric intensive care unit after normal results of coagulation and platelet studies were confirmed. The decision to use the right or left side was based primarily on the location of intracranial injury, skull fracture, and skin covering; in ambivalent situations, the right side was preferred. The insertion point for all monitoring devices was approximately 1 cm anterior to the coronal suture in the midpupillary line. The area of interest was shaved and aseptically draped, and local anesthetic was infiltrated. A stab incision was made through the skin down to the bone. A twist-drill hole was then made through the skull, and the dura was pierced with an 18-gauge spinal needle. If a fiberoptic device was placed, the Camino bolt was screwed manually into the bone and the catheter was connected to a monitor, calibrated to zero, and then placed through the bolt approximately 2 cm into the brain parenchyma. If an EVD was placed, the catheter was directed using anatomical landmarks into the frontal horn of the lateral ventricle, tunneled subcutaneously to a distant site, and secured to the skin by using 2-0 silk ties. No more than three attempts were made to cannulate the ventricle. The catheter was connected to an external drainage bag and left open at 10 to 15 cm H 2 O above the ear. If a second monitor was used concomitantly, it was placed through a separate incision just anterior to the first monitor. Personal preferences of the senior authors (J.R.W.K., D.L.B., M.L.W.) determined which monitor type was used or whether dual monitoring was used. Monitoring was discontinued when ICP and waveforms returned to normal after the patient was successfully weaned from ICP lowering maneuvers.
Outcome Criteria
Intracranial hemorrhage attributable to the placement of the monitoring device was defined as a new area of hemorrhage adjacent to the probe, which could be demonstrated on a postprocedure head CT scan. In all cases of dual monitoring, the location of the hemorrhage made it possible to determine which monitoring device was responsible for the hemorrhage. Malpositioned EVDs were defined as those catheters shown on a CT scan to be outside the ventricular system and which required a second procedure for replacement of the device. External ventricular drains that were found in locations other than the frontal horn on postprocedure CT scanning (third ventricle, contralateral lateral ventricle) but that continued to drain CSF were not considered complications. Meningitis and ventriculitis were diagnosed from positive CSF cultures. No prophylactic antibiotic agents were administered during the ICP monitoring. Cerebrospinal fluid was cultured only when a fever was present, because routine analysis of CSF in children with EVDs is not supported by the literature.
14 Results Among children consecutively evaluated over a 5-year period at a Level 1 trauma and regional medical center, ICP monitoring was performed in 80 patients. More than one procedure was performed in 50 children for a total of 130 procedures. Eighteen children (22.5%) underwent placement of an EVD only, 18 (22.5%) received a fiberoptic intraparenchymal device only, and 44 (55%) underwent placement of both. In six patients, it was necessary to place a second EVD; therefore, a total of 62 fiberoptic devices (48%) were implanted and 68 EVDs (52%) were placed.
Hemorrhagic Complications
A total of 114 procedures (87.7%) were performed without any hemorrhagic complications. To facilitate comparisons, we classified hemorrhages according to the grading system recently proposed by Blaha and colleagues. 5 Grade I hemorrhages are small punctate hemorrhages or localized subarachnoid hemorrhages; Grade II hemorrhages are larger bleeds that do not cause a new neurological deficit or require surgical evacuation, but may alter readings of ICP; and Grade III hemorrhages cause a new deficit or necessitate surgical removal (Fig. 1) . Twelve (17.6%) of 68 EVD insertions led to hemorrhagic complications detected on postprocedure CT scans: three (25%) of these were Grade I, eight (67%) were Grade II, and one (8%) was Grade III. In comparison, four (6.5%) of 62 patients who received fiberoptic intraparenchymal monitors had hemorrhagic complications: three (75%) of these were Grade I; one (25%) was Grade II; and none was Grade III (Table 1 ). The difference in the incidence of hemorrhagic complications resulting from placement of EVDs and intraparenchymal fiberoptic monitors reached statistical significance (p = 0.025). There was no difference in the incidence of hemorrhage in patients receiving EVDs only and those receiving both a fiberoptic intraparenchymal monitor and an EVD (p = 0.79).
Infection Complications
There were no complications due to infection in the 62 patients receiving fiberoptic intraparenchymal monitors. One (1.6%) of 62 patients in whom an EVD was placed suffered an infection complication. An EVD was removed from this patient after 9 days, and cultures grew Staphlococcus aureus.
Malpositioned Catheters and Mechanical Failure
Six (8.8%) of 68 EVD insertions resulted in malpositions and replacement was required (Fig. 2) . Of note, three (50%) of these reinsertions resulted in hemorrhagic complications. None of the fiberoptic monitors had to be replaced because of mechanical failure.
Discussion
Given all of the clinical indications for its use, ICP monitoring has had the most positive impact on the management of severe TBI. 19 Abnormal elevations of ICP commonly occur in patients with TBI, and numerous studies show that control of ICP improves outcome. 3, 10, 21, 27, 35 Although ICP monitoring has become routine, there are no guidelines regarding whether to use an intraparenchymal fiberoptic monitor or an EVD when monitoring is desired after TBI. The device selected is at present dictated primarily by the surgeon's personal preference.
Both types of monitors have advantages and disadvantages. Many surgeons prefer the EVD because it is considered the gold standard, and problems with its operation are easy to troubleshoot. Use of the ventricular catheter has the added advantage of allowing the therapeutic drainage of CSF to lower ICP. 16, 27 This device also requires that the brain be fully penetrated; requires some skill in placement, especially in the case of small of shifted ventricles; can malfunction or dampen secondary to air locks and debris; and its placement produces a small but definite risk of infection. The advantage of the fiberoptic monitoring device system is ease of placement; that is, it allows direct measurement of brain tissue pressure in patients with compressed or dislocated ventricles in which placement of EVDs would be difficult, 12, 16 which is especially important in children, because ventricle size is small unless the child has hydrocephalus. 9 Disadvantages of the device include fragility, mechanical failure, higher complexity and expense, and incompatibility with magnetic resonance units. In addition it is not possible to recalibrate this device in situ if the monitor becomes subject to drift or dampening of waveforms. 7, 12, 29, 40 Accidental displacement, fracture, or monitor malfunction requiring replacement has been reported in up to 13% of patients. 16, 32, 33 Several studies in adults have demonstrated that the complications of ICP monitoring are at least in part dependent on the type of monitor used. 13, 17, 34 Because EVDs are larger than the fiberoptic intraparenchymal monitors, require the brain to be completely penetrated, and may require multiple passes through the brain, it is not surprising that the highest reported hemorrhagic complication rates occur when placing EVDs. orrhage produced by EVDs is between 2 and 10%. 11, 27, 28, 41 Our hemorrhagic complication rate of 17.6% is substantially higher than those previously reported. There are at least two possible explanations for this difference. First, standardized evaluation of CT scans obtained after EVD insertion was not performed in most earlier studies, 41 so small hemorrhages likely went undetected. Second, previous studies have included primarily adult patients or children with hydrocephalus, both of whom are likely to have substantially larger ventricles than children after TBI. We do not think that unusual technical issues are responsible for the increased hemorrhagic rate seen after EVD insertion. No more than three passes were performed to attempt ventricular cannulation. Furthermore, if any of our techniques in drilling or dural penetration were responsible for an increased hemorrhage rate after EVD insertion, we would also expect a higher rate of hemorrhage after fiberoptic monitor insertion, which we did not find (6.4%). Because normal coagulation studies and platelet levels were required before EVD placement, we do not think that unusual coagulopathies are responsible for the increased hemorrhagic rate seen after EVD insertion.
We and other authors recognize that the high hemorrhagic complication rates associated with these intraventricular monitors are in most cases radiographic findings without clinical significance. 17, 22 Although this is certainly true, it can often be difficult to evaluate the clinical importance of hemorrhages in children after TBI because they are often paralyzed and sedated as an early measure to reduce elevated ICP. These children may require additional diagnostic studies to monitor their evolution and therapeutic intervention to replace the monitoring device. Paralysis and sedation may cause a false reading of ICP.
The reported incidences of hemorrhagic complications from intraparenchymal monitors ranges from 0 to 10%. 4, 6, 8, 13, 16, 22, 26, 33, 37, 42, 43 The three previously published studies in which only children were included reported hemorrhagic complications of 0, 0.3, and 9.7%. 5, 16, 33 Our hemorrhage rate of 6.4% is similar to prior reports.
In our series, there was only one infection (1.6%) in a 12-year-old child in whom an EVD had been placed for 9 days. The low infection rate was rather surprising because we hypothesized that children with thinner scalps in the setting of high ICP would have an increased risk for CSF leak and infection. The reported range of infection rate for EVDs varies from 0 to 45%, with authors of most large series and reviews indicating that the risk of infection is approximately 10%. 18, 20 We did not prophylactically change EVDs or administer antibiotic agents because the risk of infection does not appear to be reduced by these measures. 18 We did not detect any infections in children in whom fiberoptic ICP monitors had been placed. These results are in agreement with prior reports that fiberoptic intraparenchymal monitoring is associated with a very low infection rate. 33, 38, 43 There was an 8.8% rate (six of 68) of malpositioned EVDs in our series. Although we expected this complication rate to be higher in this population because of the smaller ventricles in children, our results are within the 1.5 to 20% rates of catheter malpositioning that have been reported previously. 13, 17, 30 The wide range of complication rates is likely due to varying criteria for a "malpositioned catheter," which have been described as anything from a functioning catheter with its tip in the third ventricle to a nonfunctional catheter requiring replacement.
The largest group of patients in our study underwent dual monitoring. We did not find any difference in the risk of complications when comparing children who received both an EVD and a fiberoptic monitor with those receiving only an EVD (p = 0.79). Some authors have advocated the use of two monitors at the same time because dual monitoring allows simultaneous therapeutic drainage of CSF through the ventricular catheter and moment-tomoment readings of ICP from the parenchymal monitor. 19, 36 This dual method may become especially valuable when ICP is elevated enough to cause collapse of the ventricular system around a ventricular catheter, making drainage of CSF at best intermittent and readings of ICP from the catheter less reliable. Another clinical situation in which dual monitoring may be helpful is when small ventricle size precludes placement of a ventricular catheter at the time therapy is initiated. Instead, a parenchymal monitor can be inserted to begin aggressive medical management. The parenchymal monitor may allow some expansion of the ventricular system such that a safer or successful cannulation of the ventricles can occur. In this situation, the parenchymal monitor remains to guide therapy, while the ventricular catheter becomes an avenue of that therapy. 19 Furthermore, the presence of two monitors allows a crosscheck of the accuracy of either monitor because differences in simultaneous recordings from intraventricular pressures and intraparenchymal monitors have been reported in some situations. 36 In our retrospective cohort of pediatric patients who sustained TBI, we found complication rates that were significantly different depending on the type of monitor used. Placement of an EVD was associated with a threefold increased risk of hemorrhage when compared with placement of a fiberoptic intraparenchymal monitor (p = 0.025). The nearly 10% rate of malpositioned catheters is a complication unique to EVDs, with half of the malpositioned catheters (three of six) leading to insertion of replacements that caused hemorrhages. Because of the small number of infections in our group of patients (one or 1.6%), no conclusions can be drawn regarding the difference in risk of infection between an EVD or fiberoptic monitor. These rates must be interpreted with caution, however, because they are raw, unadjusted measurements of risk. Furthermore, it is important to note that the majority of these complications did not cause clinical sequelae. The retrospective nature of this study and the relatively small number of patients are additional limitations of this report.
Conclusions
Although ICP monitoring has played an important role in improving outcomes in patients with TBI, the procedure is not without risk. We found an overall complication rate of 28% for patients in whom EVDs had been placed and 6.5% for those in whom a fiberoptic intraparenchymal monitor was placed. There is no clear standard of care regarding whether to use an intraparenchymal fiberoptic monitor or an EVD when ICP monitoring is desired in children with TBI. Because the complication rate associated with the use of an EVD is significantly higher than that with the use of a fiberoptic intraparenchymal device in children with TBI, it seems reasonable to consider a fiberoptic device first unless there are compelling reasons for immediate ventricular drainage. Although the majority of these complications were clinically insignificant, surgeons should be aware of these different complication rates when choosing the most appropriate device for each patient.
